Wynn Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
19,856
-105
-0.5% -$9.37K 0.92% 34
2026
Q1
$1.43M Sell
19,961
-181
-0.9% -$13.9K 0.74% 40
2025
Q4
$1.6M Buy
20,142
+81
+0.4% +$6.39K 0.78% 37
2025
Q3
$1.51M Buy
20,061
+340
+2% +$23.3K 0.73% 37
2025
Q2
$1.36M Buy
19,721
+251
+1% +$16.5K 0.73% 39
2025
Q1
$1.32M Buy
19,470
+530
+3% +$31.7K 0.78% 38
2024
Q4
$850K Sell
18,940
-215
-1% -$12.1K 0.54% 49
2024
Q3
$1.2M Buy
19,155
+1,280
+7% +$74.7K 0.79% 39
2024
Q2
$1.06M Buy
17,875
+260
+1% +$16.3K 0.78% 38
2024
Q1
$1.4M Buy
17,615
+413
+2% +$31.5K 1.09% 32
2023
Q4
$1.36M Buy
+17,202
New +$1.22M 1.11% 29

Other funds holding CVS

Wynn Capital's CVS Position: Q2 2026 in Review

Wynn Capital reduced its CVS Health (CVS) stake by 0.53% in Q2 2026, selling an estimated $9.37K and leaving 19,856 shares worth $2.05M. The position accounts for 0.92% of the portfolio, ranked #34.

Wynn Capital first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. 928 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Wynn Capital held 19,856 shares of CVS Health worth $2.05M as of Q2 2026.
  • Wynn Capital sold 105 CVS Health shares in Q2 2026, an estimated $9.37K.
  • CVS Health made up 0.92% of Wynn Capital's portfolio in Q2 2026, its #34 holding.
  • Wynn Capital first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • 928 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.